Limits of genotoxic impurities in medicines - a threshold and pragmatic approach

被引:0
|
作者
Mauthe, Robert J. [1 ]
机构
[1] Pfizer Global Res & Dev, Genet Toxicol, Ann Arbor, MI 48105 USA
关键词
D O I
10.1016/j.tox.2006.05.045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:31 / 31
页数:1
相关论文
共 50 条
  • [21] Genotoxic and non-genotoxic impurities in pharmaceuticals Current regulations, status and trend
    Roy, Arindam
    Nyarady, Stefan
    Matchett, Michael
    [J]. CHIMICA OGGI-CHEMISTRY TODAY, 2009, 27 (02) : xix - xxiii
  • [22] THRESHOLD LIMITS
    TAYLOR, R
    [J]. NEW SOCIETY, 1974, 27 (594): : 454 - 455
  • [23] Advances on genotoxic impurities of sulfonate esters in pharmaceuticals
    Liu Xuewei
    Li Cheng
    Han Haiyun
    Zhang Wenpeng
    Chen Dongying
    [J]. CHINESE JOURNAL OF CHROMATOGRAPHY, 2018, 36 (10) : 952 - 961
  • [24] Genotoxic impurities in production batches of drug substances
    O'Donovan, Mike
    [J]. MUTAGENESIS, 2010, 25 (06) : 639 - 640
  • [25] Genotoxic impurities: Safety in a Pandora's box?
    Goldfain-Blanc, Francoise
    Wattrelos, Olivier
    Lorge, Elisabeth
    Gervais, Veronique
    Gignoux, Claire
    Claude, Nancy
    [J]. TOXICOLOGY LETTERS, 2009, 189 : S272 - S272
  • [26] Comprehensive Toxicology Risk Assessment for Genotoxic Impurities
    Bercu, Joel P.
    Callis, Courtney M.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (05) : 938 - 938
  • [28] Review of Genotoxic Impurities: Strategies for Identification and Control
    Theresa Allio
    [J]. Drug information journal : DIJ / Drug Information Association, 2012, 46 (2): : 235 - 236
  • [29] Analytical challenges in stability testing for genotoxic impurities
    Liu, David Q.
    Kord, Alireza S.
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2013, 49 : 108 - 117
  • [30] The EMEA/CPMP initiative on genotoxic impurities in pharmaceuticals
    Mueller, L
    [J]. MUTAGENESIS, 2004, 19 (06) : 508 - 508